Travere Therapeutics, Inc. · NASDAQ:TVTX
State Street Corp's stake in Travere Therapeutics, Inc. fell to 4.60% (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp's stake in Travere Therapeutics, Inc. fell to 4.60%, 4,256,224 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 4.60%
- Shares
- 4,256,224
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.60% | 4,256,224 |
Source
Related
- Travere Therapeutics, Inc.
- State Street Corp
- Travere Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Feb 9, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026